Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2026-02-26 @ 4:13 PM
Study NCT ID:
NCT00862251
Status:
COMPLETED
Last Update Posted:
2024-05-16
First Post:
2009-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ezetimibe/Simvastatin (MK-0653A) Versus Rosuvastatin Versus Doubling Statin Dose in Participants With Cardiovascular Disease and Diabetes Mellitus (MK-0653A-133)(COMPLETED)
Sponsor:
Organon and Co
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0653A-133
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None